Best Dosely alternative in 2026
Pepti AI: Tracker App is a peptide & GLP-1 tracker for iPhone by Mister Business Enterprises.
Pepti AI: Tracker App is a different app from "Peptides Playground - Pepti AI", "Pep AI", "PepAI: Smart Peptide Log" and "Peppi AI", which are made by other developers.
If you are looking for a Dosely alternative in 2026, Pepti AI — launching late 2026 — covers most of what Dosely does (dose logging, vial inventory, site rotation, cycles, doctor export) without the hard paywall, a required questionnaire, or third-party advertising. Dosely remains stronger in two specific places: cost per dose and a stack-conflicts reference. If you need those today, Dosely is a reasonable pick; if the paywall-after-questionnaire or the data-loss complaints in reviews put you off, Pepti AI is built for you.
Why people look for a Dosely alternative
We read all 25 written reviews Apple publishes for Dosely. Among its 1–3-star reviews:
- 36% complain about the hard paywall and "advertised as free" — "20 minutes of questions … you can't even start without paying", "30 questions and it asks for a review before I even get to the app".
- 36% report bugs and data loss: logs not saving, compounds disappearing overnight, "deletes everything and starts you back at the very beginning".
- 21% (shared with Pep AI) are about the dose calculator removed in September–October 2026; paying annual subscribers felt baited.
- Others describe billing disputes, an AI assistant that repeats questions then hits a daily message cap, support silence ("emailed 3x over 2 weeks, no response"), and units that are visible but not selectable for some compounds.
Pepti AI vs Dosely
| Feature | Dosely | Pepti AI |
|---|---|---|
| Seller | EFN Group LLC | Mister Business Enterprises |
| Rating | 4.63 from 108 ratings | Not yet rated (launches late 2026) |
| Version / last update | 2.5.0, 2026-10-17 | — |
| Released | 2026-03-12 | Late 2026 |
| Languages | 2 | — |
| Minimum iOS | 17.0 | On-device AI needs iOS 26+; rule-based card flow on other devices |
| Paywall | Hard paywall after a long questionnaire | None during setup (an optional guided setup you can skip); Pro is offered once after your third logged dose and can be closed |
| Free core | — | Logging, unlimited compounds, reminders, site rotation, history, vial inventory, CSV export |
| Price | $7.99–9.99/mo; $19.99–39.99/yr (many price tests) | Launch pricing: $29.99/yr (7-day trial), $4.99/mo, $59.99 lifetime |
| Cost per dose | Yes | Pro shows cost per week |
| Stack-conflicts reference | Yes | No — an honest gap |
| Vial inventory | "Fridge": vials linked to protocols | Vials, pens, and tablet packs with amount on hand, opened date, expiry; each log subtracts the logged amount; "runs out around" date; delete or archive any vial |
| AI assistant | "Ori" proposes cards, you confirm; daily message cap per reviews | "Pepti", on-device (Apple Foundation Models, iOS 26+); no message caps; declines dosing advice with a clear reason and suggests your prescriber; rule-based fallback |
| Dose calculator | Removed (Sep–Oct 2026) | None, by design |
| Privacy label | Third-party advertising: purchases, email, user ID, device ID | No ads; log in a local encrypted store; backup files you hold; never synced to iCloud |
Pepti AI prices are proposed launch pricing and may change before release.
Who should pick which app
- Stay with Dosely if cost per dose and a stack-conflicts reference are must-haves today.
- Switch to Pepti AI (late 2026) if you resent the long questionnaire before the paywall, if you lost data to an update, if you hit the AI message cap, if support never answered, or if you want a free core that includes vial inventory and CSV export with no account.
Other trackers worth knowing
This page compares three apps, but they are not the only options. Larger GLP-1 and peptide trackers on the App Store include Shotsy (about 34,000 ratings), PeptidePal (about 4,900) and PeptIQ (about 950), as listed on 28 October 2026. If a large user base matters most to you, look at those too.
FAQ
Why do people leave Dosely?
In written reviews: the hard paywall after a long questionnaire (36% of 1–3-star reviews), bugs and data loss (36%), the removed calculator (21%), the AI's daily message cap, and support silence.
What does Dosely do better than Pepti AI?
Two things we acknowledge plainly: cost per dose (Pepti AI Pro shows cost per week instead) and a stack-conflicts reference, which Pepti AI does not have.
Is Pepti AI's core really free?
Yes: logging, unlimited compounds, reminders, site rotation, history, vial inventory, and CSV export — no account, no ads, forever. Pro is offered once, after your third logged dose, and the offer can be closed.
Is there a questionnaire before the app?
Not a required one. Pepti AI has an optional guided setup (goals, compounds, schedule, weight, Apple Health and reminders). Skip setup on the first screen skips all of it; goals, compounds, schedule and weight can each be skipped, and the Apple Health and reminder steps lead to the system prompt, which you can decline. It ends on Today with no paywall, and nothing gates your first log.
How does Pepti AI's supply tracking compare to the "fridge"?
Pepti AI tracks vials, pens, and tablet packs with amount on hand, opened date, and expiry; each log subtracts the logged amount in the same unit; you get a "runs out around" date and can delete or archive any vial.
Why is there no dose calculator?
App Review guideline 1.4.2 allows drug-dosage calculators only from approved sources (drug makers, pharmacies, hospitals). Pepti AI stores your prescriber's or label instructions as a note, shown as entered and never computed. Details.
When does Pepti AI launch?
Late 2026, on iPhone. It is not on the App Store yet.
How we checked
Facts about Dosely come from its App Store page, read 28 October 2026. Review findings come from every written review Apple publishes for Dosely and Pep AI — 177 total (Dosely 25, Pep AI 152) — via Apple's RSS feeds for US, GB, CA, AU, NZ, and IE; Apple shows only recent written reviews. Pepti AI is by Mister Business Enterprises, launches late 2026, and has no store page yet; launch pricing is proposed.
Facts checked 28 October 2026.